Vestal Point Capital »

Ibio shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Ibio (IBIO) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Ibio

Tip: Access up to 7 years of quarterly data

All positions including Ibio held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ibio by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.6M 2.6M 1.75

More positions owned by Vestal Point Capital

BioMarin Pharmaceutical (BMRN)
Neurocrine Biosciences (NBIX)
Abivax SA Sponsored Ads (ABVX)
United Therapeutics Corporation (UTHR)
Enliven Therapeutics (ELVN)
Nurix Therapeutics (NRIX)
Bicara Therapeutics (BCAX)
Taysha Gene Therapies Com Shs (TSHA)
Arrowhead Pharmaceuticals (ARWR)
Abbott Laboratories (ABT)
Zimmer Holdings (ZBH)
Disc Medicine (IRON)
Monte Rosa Therapeutics (GLUE)
Insulet Corporation (PODD)
Ascendis Pharma A/S Ord Shs (ASND)

View all positions for Vestal Point Capital

Top funds holding Ibio

Affinity Asset Advisors
Cormorant Asset Management
Silverarc Capital Management
Vestal Point Capital
Vanguard Capital Management
Frazier Life Sciences Management
Ensign Peak Advisors
Woodline Partners
Millennium Management
Citadel Advisors
Balyasny Asset Management
Bank of America Corporation
Ikarian Capital
Sio Capital Management
Marshall Wace

View all funds holding Ibio